Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
PhenoMiner Database Result        View data table  |  Download data table  |  View compact data table        


Generate Chart For    
    (Chart displayed below)
Rat Strains

{{sample.term}}
Measurement Methods

{{method.term}}
Age

{{ageRange}}
Experimental Conditions

     {{ cond }}

Minimum Value:    Maximum Value:    Sex:


 
Options:  View chart  |  Download data table  |  View compact data table
Study IDStudyExperiment NameExperiment NotesStrain Ont IDStrainSexAge# of AnimalsSample NotesClinical Measurement Ont IDPhenotypeFormulaClinical Measurement NotesAverage TypeValueUnitsSEMSDMethod Ont IDMethodMethod SiteMethod DurationMethod NotesPost Insult TypePost Insult Time ValuePost Insult Time UnitConditionsRecord IDCondition 1Condition 2Condition 3Condition 4
2803Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18.blood insulin amountRS:0000784SRmale126 days13CMO:0000342plasma insulin level5mU/l0.27741.0MMO:0000321plasma insulin analysis0.0controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 84 days)103331controlled sodium content diet (0.3 %) (for 42 days)controlled sodium content diet (8 %) (for 84 days)
2803Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18.blood insulin amountRS:0000789SSmale126 days12CMO:0000342plasma insulin level6mU/l0.57742.0MMO:0000321plasma insulin analysis0.0controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 84 days)103330controlled sodium content diet (0.3 %) (for 42 days)controlled sodium content diet (8 %) (for 84 days)
2803Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18.blood insulin amountRS:0000784SRmale84 days11CMO:0000342plasma insulin level5mU/l0.6032.0MMO:0000321plasma insulin analysis0.0controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days)103329controlled sodium content diet (0.3 %) (for 42 days)controlled sodium content diet (8 %) (for 42 days)
2803Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18.blood insulin amountRS:0000789SSmale84 days13CMO:0000342plasma insulin level5mU/l0.55472.0MMO:0000321plasma insulin analysis0.0controlled sodium content diet (0.3 %) (for 42 days) then controlled sodium content diet (8 %) (for 42 days)103328controlled sodium content diet (0.3 %) (for 42 days)controlled sodium content diet (8 %) (for 42 days)
2803Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18.blood insulin amountRS:0000784SRmale42 days13CMO:0000342plasma insulin level4mU/l0.27741.0MMO:0000321plasma insulin analysis0.0controlled sodium content diet (0.3 %) (for 42 days)103327controlled sodium content diet (0.3 %) (for 42 days)
2803Fujii N, et al., Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H760-6. doi: 10.1152/ajpheart.00734.2003. Epub 2004 Mar 18.blood insulin amountRS:0000789SSmale42 days12CMO:0000342plasma insulin level4mU/l0.57742.0MMO:0000321plasma insulin analysis0.0controlled sodium content diet (0.3 %) (for 42 days)103326controlled sodium content diet (0.3 %) (for 42 days)
1540Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7.blood insulin amountRS:0000695Crl:SDmale77 days to 63 days8CMO:0000342plasma insulin levelCT26mU/l2.05.6569MMO:0000073radioimmunoassay0.0controlled metformin content drinking water (350~500 mg/kg/d) (between 21 and 35 days)75850controlled metformin content drinking water (350~500 mg/kg/d) (between 21 and 35 days)
1540Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7.blood insulin amountRS:0000695Crl:SDmale77 days to 63 days10CMO:0000342plasma insulin levelFT32mU/l4.012.6491MMO:0000073radioimmunoassay0.0controlled metformin content drinking water (350~500 mg/kg/d) (between 21 and 35 days) then controlled fructose content diet (66 %) (between 14 and 28 days)75849controlled metformin content drinking water (350~500 mg/kg/d) (between 21 and 35 days)controlled fructose content diet (66 %) (between 14 and 28 days)
1540Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7.blood insulin amountRS:0000695Crl:SDmale77 days to 63 days8CMO:0000342plasma insulin levelC33mU/l2.05.6569MMO:0000073radioimmunoassay0.0naive control condition75848naive control condition
1540Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7.blood insulin amountRS:0000695Crl:SDmale77 days to 63 days9CMO:0000342plasma insulin levelF51mU/l7.021.0MMO:0000073radioimmunoassay0.0controlled fructose content diet (66 %) (between 14 and 28 days)75847controlled fructose content diet (66 %) (between 14 and 28 days)
1540Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7.blood insulin amountRS:0000695Crl:SDmale0 days8CMO:0000342plasma insulin levelFT68mU/l3.08.4853MMO:0000073radioimmunoassay0.0controlled metformin content drinking water (350~500 mg/kg/d) (between 21 and 35 days) then controlled fructose content diet (66 %) (between 14 and 28 days) then insulin (2 U/kg/d) (for 14 days)75880controlled metformin content drinking water (350~500 mg/kg/d) (between 21 and 35 days)controlled fructose content diet (66 %) (between 14 and 28 days)insulin (2 U/kg/d) (for 14 days)
1540Verma S, et al., J Pharmacol Exp Ther. 1994 Dec;271(3):1334-7.blood insulin amountRS:0000695Crl:SDmale0 daysN/ACMO:0000342plasma insulin levelF53mU/l7.0MMO:0000073radioimmunoassay0.0controlled fructose content diet (66 %) (between 14 and 28 days)75879controlled fructose content diet (66 %) (between 14 and 28 days)
107Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22blood insulin amountRS:0000916WKY/NHsdmale119 days10CMO:0000342plasma insulin level64.1mU/l9.730.6741MMO:0000164intraperitoneal glucose tolerance test0post glucose injection60minfasting (for 16 hours) then glucose solution (2 g/kg) 11612fasting (for 16 hours)glucose solution (2 g/kg)
107Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22blood insulin amountRS:0000363F344/NHsdmale119 days10CMO:0000342plasma insulin level43mU/l4.614.5465MMO:0000164intraperitoneal glucose tolerance test0post glucose injection60minfasting (for 16 hours) then glucose solution (2 g/kg) 11613fasting (for 16 hours)glucose solution (2 g/kg)
107Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22blood insulin amountRS:0000916WKY/NHsdfemale119 days10CMO:0000342plasma insulin level20mU/l2.57.9057MMO:0000164intraperitoneal glucose tolerance test0post glucose injection60minfasting (for 16 hours) then glucose solution (2 g/kg) 11614fasting (for 16 hours)glucose solution (2 g/kg)
107Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22blood insulin amountRS:0000363F344/NHsdfemale119 days10CMO:0000342plasma insulin level17mU/l2.47.5895MMO:0000164intraperitoneal glucose tolerance test0post glucose injection60minfasting (for 16 hours) then glucose solution (2 g/kg) 11615fasting (for 16 hours)glucose solution (2 g/kg)
2645Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93.blood insulin amountRS:0003219BN-Chr 13LH/MavRrrcmale175 days9CMO:0000342plasma insulin level23.41mU/l1.885.64MMO:0000073radioimmunoassay0.0controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 12 days)102095controlled sodium chloride content drinking water (1 %) (for 7 days)controlled sodium chloride content drinking water (2 %) (for 7 days)controlled sodium chloride content drinking water (1 %) (for 9 days)water (for 12 days)
2645Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93.blood insulin amountRS:0002068LH-Chr 13BN/Mavmale175 days10CMO:0000342plasma insulin level30.84mU/l1.625.1229MMO:0000073radioimmunoassay0.0controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 12 days)102094controlled sodium chloride content drinking water (1 %) (for 7 days)controlled sodium chloride content drinking water (2 %) (for 7 days)controlled sodium chloride content drinking water (1 %) (for 9 days)water (for 12 days)
2645Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93.blood insulin amountRS:0000556LH/Mavmale175 days10CMO:0000342plasma insulin level29.17mU/l1.424.4904MMO:0000073radioimmunoassay0.0controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 12 days)102093controlled sodium chloride content drinking water (1 %) (for 7 days)controlled sodium chloride content drinking water (2 %) (for 7 days)controlled sodium chloride content drinking water (1 %) (for 9 days)water (for 12 days)
2645Gilibert S, et al., J Hypertens. 2009 Jun;27(6):1186-93.blood insulin amountRS:0000145BN/NHsdMcwimale175 days10CMO:0000342plasma insulin level20.37mU/l0.912.8777MMO:0000073radioimmunoassay0.0controlled sodium chloride content drinking water (1 %) (for 7 days) then controlled sodium chloride content drinking water (2 %) (for 7 days) then controlled sodium chloride content drinking water (1 %) (for 9 days) then water (for 12 days)102092controlled sodium chloride content drinking water (1 %) (for 7 days)controlled sodium chloride content drinking water (2 %) (for 7 days)controlled sodium chloride content drinking water (1 %) (for 9 days)water (for 12 days)
3070Mine T, etal., Biol Pharm Bull. 2002 Nov;25(11):1412-6. doi: 10.1248/bpb.25.1412.blood insulin amountRS:0001095ZUC-Lepr+Stemale105 days to 84 days9CMO:0000342plasma insulin level26mU/l2.67.8MMO:0000075enzyme linked immunosorbent assay0.0enzyme immunoassay (MMO:0000713)fasting (for 17 hours)108658fasting (for 17 hours)
3070Mine T, etal., Biol Pharm Bull. 2002 Nov;25(11):1412-6. doi: 10.1248/bpb.25.1412.blood insulin amountRS:0004817GK/CskCrljmale238 days to 224 days10CMO:0000342plasma insulin level28.6mU/l2.68.2219MMO:0000075enzyme linked immunosorbent assay0.0enzyme immunoassay (MMO:0000713)fasting (for 17 hours)106892fasting (for 17 hours)
3070Mine T, etal., Biol Pharm Bull. 2002 Nov;25(11):1412-6. doi: 10.1248/bpb.25.1412.blood insulin amountRS:0001098ZUC-LeprfaSte-/-male105 days to 84 days44CMO:0000342plasma insulin level384.8mU/l41.6275.9432MMO:0000075enzyme linked immunosorbent assay0.0enzyme immunoassay (MMO:0000713)fasting (for 17 hours)106938fasting (for 17 hours)
3070Mine T, etal., Biol Pharm Bull. 2002 Nov;25(11):1412-6. doi: 10.1248/bpb.25.1412.blood insulin amountRS:0001036WKY/NCrlCrljmale238 days to 224 days5CMO:0000342plasma insulin level62.4mU/l10.423.2551MMO:0000075enzyme linked immunosorbent assay0.0enzyme immunoassay (MMO:0000713)fasting (for 17 hours)108088fasting (for 17 hours)
3111Weng S, etal., Obes Surg. 2017 Mar;27(3):657-664. doi: 10.1007/s11695-016-2320-z.blood insulin amountRS:0001299GKmale77 days10CMO:0000342plasma insulin levelplasma glucagon-like peptide 1 level (CMO:0003638)11.7mU/l0.16440.52MMO:0000075enzyme linked immunosorbent assay0.0fasting (for 16 hours)109085fasting (for 16 hours)
3111Weng S, etal., Obes Surg. 2017 Mar;27(3):657-664. doi: 10.1007/s11695-016-2320-z.blood insulin amountRS:0001299GKmale77 days10CMO:0000342plasma insulin levelplasma glucagon-like peptide 1 level (CMO:0003638)11.44mU/l0.16440.52MMO:0000075enzyme linked immunosorbent assay0.0fasting (for 16 hours)109083fasting (for 16 hours)
3111Weng S, etal., Obes Surg. 2017 Mar;27(3):657-664. doi: 10.1007/s11695-016-2320-z.blood insulin amountRS:0001299GKmale77 days10CMO:0000342plasma insulin levelplasma glucagon-like peptide 1 level (CMO:0003638)11.96mU/l0.32891.04MMO:0000075enzyme linked immunosorbent assay0.0fasting (for 16 hours)109082fasting (for 16 hours)
2782Apaijai N, et al., Biosci Rep. 2017 Oct 17;37(5). pii: BSR20170886. doi: 10.1042/BSR20170886. Print 2017 Oct 31.blood insulin amountRS:0001299GKfemale87 days6CMO:0000342plasma insulin level23.4mU/l5.212.7373MMO:0000075enzyme linked immunosorbent assay0.0bilateral ovariectomy (for 24 days)103764bilateral ovariectomy (for 24 days)
2782Apaijai N, et al., Biosci Rep. 2017 Oct 17;37(5). pii: BSR20170886. doi: 10.1042/BSR20170886. Print 2017 Oct 31.blood insulin amountRS:0001299GKfemale87 days6CMO:0000342plasma insulin level26mU/l2.66.3687MMO:0000075enzyme linked immunosorbent assay0.0sham surgical control condition (for 24 days)103763sham surgical control condition (for 24 days)
2782Apaijai N, et al., Biosci Rep. 2017 Oct 17;37(5). pii: BSR20170886. doi: 10.1042/BSR20170886. Print 2017 Oct 31.blood insulin amountRS:0001833Crl:WI(Han)female87 days6CMO:0000342plasma insulin level213.2mU/l46.8114.6361MMO:0000075enzyme linked immunosorbent assay0.0bilateral ovariectomy (for 24 days)103762bilateral ovariectomy (for 24 days)
2782Apaijai N, et al., Biosci Rep. 2017 Oct 17;37(5). pii: BSR20170886. doi: 10.1042/BSR20170886. Print 2017 Oct 31.blood insulin amountRS:0001833Crl:WI(Han)female87 days6CMO:0000342plasma insulin level221mU/l44.2108.2674MMO:0000075enzyme linked immunosorbent assay0.0sham surgical control condition (for 24 days)103761sham surgical control condition (for 24 days)
933Ways JA, et al., Physiol Genomics. 2006 Dec 19;.blood insulin amountRS:0001216COP.DA-(D3Rat233-D3Mgh14)/Mconot specified105 days10CMO:0000342plasma insulin level26.52mU/l8.0625.488MMO:0000075enzyme linked immunosorbent assay0.0fasting (for 16 hours)68574fasting (for 16 hours)
933Ways JA, et al., Physiol Genomics. 2006 Dec 19;.blood insulin amountRS:0001215COP.DA-(D16Rat12-D16Rat90)/Mconot specified105 days10CMO:0000342plasma insulin level32.5mU/l7.5423.8436MMO:0000075enzyme linked immunosorbent assay0.0fasting (for 16 hours)68573fasting (for 16 hours)
933Ways JA, et al., Physiol Genomics. 2006 Dec 19;.blood insulin amountRS:0000186COP/OlaHsdnot specified105 days10CMO:0000342plasma insulin level29.12mU/l5.7218.0882MMO:0000075enzyme linked immunosorbent assay0.0fasting (for 16 hours)68572fasting (for 16 hours)
1037Klimes I, et al., Diabetologia 2003 Mar;46(3):352-8.blood insulin amountRS:0000148BN/OrlIcoCrlfnot specified120 days10CMO:0000342plasma insulin level14.04mU/l1.97336.24MMO:0000321plasma insulin analysis0.0fasting (for 16 hours)68985fasting (for 16 hours)
1037Klimes I, et al., Diabetologia 2003 Mar;46(3):352-8.blood insulin amountRS:0000397HTGnot specified120 days10CMO:0000342plasma insulin level13mU/l2.71328.58MMO:0000321plasma insulin analysis0.0fasting (for 16 hours)68984fasting (for 16 hours)
1012Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29.blood insulin amountRS:0002495GK/Oxfemale60 days6CMO:0000342plasma insulin level9.1mU/l1.3783.3754MMO:0000075enzyme linked immunosorbent assay0.0fasting (between 16 and 18 hours)68779fasting (between 16 and 18 hours)
1012Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29.blood insulin amountRS:0002495GK/Oxmale60 days6CMO:0000342plasma insulin level18.798mU/l2.3925.8592MMO:0000075enzyme linked immunosorbent assay0.0fasting (between 16 and 18 hours)68778fasting (between 16 and 18 hours)
1012Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29.blood insulin amountRS:0000134BN/Crlfemale60 days6CMO:0000342plasma insulin level6.058mU/l0.8061.9743MMO:0000075enzyme linked immunosorbent assay0.0fasting (between 16 and 18 hours)68777fasting (between 16 and 18 hours)
1012Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29.blood insulin amountRS:0000134BN/Crlmale60 days6CMO:0000342plasma insulin level6.396mU/l1.1182.7385MMO:0000075enzyme linked immunosorbent assay0.0fasting (between 16 and 18 hours)68776fasting (between 16 and 18 hours)
66Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26blood insulin amountRS:0000117BN.GK-(D8Got302-D8Got130)/Oxmale168 days10CMO:0000342plasma insulin level5.323745mU/l0.71942.275MMO:0000326intravenous glucose tolerance test0.0plasma insulin analysisnaive control condition67338naive control condition
66Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26blood insulin amountRS:0000119BN.GK-(D8Rat29-D8Got130)/Oxfemale168 days7CMO:0000342plasma insulin level4.31655mU/l0.86332.2841MMO:0000326intravenous glucose tolerance test0.0plasma insulin analysisnaive control condition67337naive control condition
66Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26blood insulin amountRS:0000134BN/Crlfemale168 days10CMO:0000342plasma insulin level7.050365mU/l1.43894.55MMO:0000326intravenous glucose tolerance test0.0plasma insulin analysisnaive control condition67336naive control condition
66Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26blood insulin amountRS:0000117BN.GK-(D8Got302-D8Got130)/Oxfemale84 days18CMO:0000342plasma insulin level2.733815mU/l0.43171.8314MMO:0000326intravenous glucose tolerance test0.0plasma insulin analysisnaive control condition67335naive control condition
66Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26blood insulin amountRS:0000119BN.GK-(D8Rat29-D8Got130)/Oxfemale84 days10CMO:0000342plasma insulin level6.04317mU/l1.00723.185MMO:0000326intravenous glucose tolerance test0.0plasma insulin analysisnaive control condition67334naive control condition
66Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26blood insulin amountRS:0000134BN/Crlfemale84 days12CMO:0000342plasma insulin level4.31655mU/l0.43171.4953MMO:0000326intravenous glucose tolerance test0.0plasma insulin analysisnaive control condition67333naive control condition
66Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26blood insulin amountRS:0000117BN.GK-(D8Got302-D8Got130)/Oxmale168 days11CMO:0000342plasma insulin level3.309355mU/l0.43171.4316MMO:0000326intravenous glucose tolerance test0.0plasma insulin analysisnaive control condition67332naive control condition
66Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26blood insulin amountRS:0000119BN.GK-(D8Rat29-D8Got130)/Oxmale168 days12CMO:0000342plasma insulin level6.762595mU/l1.2954.4859MMO:0000326intravenous glucose tolerance test0.0plasma insulin analysisnaive control condition67331naive control condition
66Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26blood insulin amountRS:0000134BN/Crlmale168 days20CMO:0000342plasma insulin level5.46763mU/l0.71943.2174MMO:0000326intravenous glucose tolerance test0.0plasma insulin analysisnaive control condition67330naive control condition
66Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26blood insulin amountRS:0000117BN.GK-(D8Got302-D8Got130)/Oxmale84 days15CMO:0000342plasma insulin level3.45324mU/l0.71942.7863MMO:0000326intravenous glucose tolerance test0.0plasma insulin analysisnaive control condition67329naive control condition
66Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26blood insulin amountRS:0000119BN.GK-(D8Rat29-D8Got130)/Oxmale84 days12CMO:0000342plasma insulin level4.02878mU/l0.71942.4922MMO:0000326intravenous glucose tolerance test0.0plasma insulin analysisnaive control condition67328naive control condition
66Wallis RH, et al., Diabetologia 2004 Jun;47(6):1096-106. Epub 2004 May 26blood insulin amountRS:0000134BN/Crlmale84 days15CMO:0000342plasma insulin level7.19425mU/l1.00723.9008MMO:0000326intravenous glucose tolerance test0.0plasma insulin analysisnaive control condition67327naive control condition